Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated:  7/11/2016
El Rio Community Health Center
mi
from
Tucson, AZ
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated: 7/11/2016
El Rio Community Health Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated:  7/11/2016
Cross Trails Medical Center
mi
from
Cape Girardeau, MO
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated: 7/11/2016
Cross Trails Medical Center
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated:  7/11/2016
Triad Adult and Pediatric Medicine, Inc.
mi
from
High Point, NC
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated: 7/11/2016
Triad Adult and Pediatric Medicine, Inc.
mi
from
High Point, NC
Click here to add this to my saved trials
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated:  7/11/2016
FamilyCare Health Center
mi
from
Scott Depot, WV
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support
Status: Enrolling
Updated: 7/11/2016
FamilyCare Health Center
mi
from
Scott Depot, WV
Click here to add this to my saved trials
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
Status: Enrolling
Updated:  7/11/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
Status: Enrolling
Updated: 7/11/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes (T2DM).
Status: Enrolling
Updated:  7/12/2016
Biofortis Clinical Research
mi
from
Addison, IL
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes (T2DM).
Status: Enrolling
Updated: 7/12/2016
Biofortis Clinical Research
mi
from
Addison, IL
Click here to add this to my saved trials
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes (T2DM).
Status: Enrolling
Updated:  7/12/2016
Radiant Research, Inc.
mi
from
Cincinnati, OH
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes.
Evaluation of a Nutritional Supplement for People With Type 2 Diabetes (T2DM).
Status: Enrolling
Updated: 7/12/2016
Radiant Research, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gestational Diabetes and Sleep-Disordered Breathing
A Pilot Study to Evaluate the Association Between Gestational Diabetes, Heart Rate Variability and Sleep-Disordered Breathing
Status: Enrolling
Updated:  7/13/2016
Christiana Care Health Services, Inc
mi
from
Newark, DE
Gestational Diabetes and Sleep-Disordered Breathing
A Pilot Study to Evaluate the Association Between Gestational Diabetes, Heart Rate Variability and Sleep-Disordered Breathing
Status: Enrolling
Updated: 7/13/2016
Christiana Care Health Services, Inc
mi
from
Newark, DE
Click here to add this to my saved trials
A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
Status: Enrolling
Updated:  7/19/2016
Diabetes Clinic, Texas Children's Hospital
mi
from
Houston, TX
A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
Status: Enrolling
Updated: 7/19/2016
Diabetes Clinic, Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Ability to Cope With Type 1 Diabetes
Evaluation of Ongoing Management of Type 1 Diabetes
Status: Enrolling
Updated:  7/19/2016
Texas Children's Hospital
mi
from
Houston, TX
Ability to Cope With Type 1 Diabetes
Evaluation of Ongoing Management of Type 1 Diabetes
Status: Enrolling
Updated: 7/19/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
Status: Enrolling
Updated:  7/19/2016
Baylor College of Medicine
mi
from
Houston, TX
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
Status: Enrolling
Updated: 7/19/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
Status: Enrolling
Updated:  7/19/2016
Texas Children's Hospital
mi
from
Houston, TX
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
Status: Enrolling
Updated: 7/19/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Disaster Preparedness Among Families Caring for Children With Diabetes
Pre-hurricane Disaster Preparedness: A Survey in Pediatric Type 1 Diabetes
Status: Enrolling
Updated:  7/19/2016
Texas Children Hospital
mi
from
Houston, TX
Disaster Preparedness Among Families Caring for Children With Diabetes
Pre-hurricane Disaster Preparedness: A Survey in Pediatric Type 1 Diabetes
Status: Enrolling
Updated: 7/19/2016
Texas Children Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated:  7/20/2016
The Rogosin Institute
mi
from
New York, NY
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated: 7/20/2016
The Rogosin Institute
mi
from
New York, NY
Click here to add this to my saved trials
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated:  7/20/2016
Weill Cornell Medical College Clinical and Translational Science Center (CTSC)
mi
from
New York, NY
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated: 7/20/2016
Weill Cornell Medical College Clinical and Translational Science Center (CTSC)
mi
from
New York, NY
Click here to add this to my saved trials
MPC Versus PID for Closed Loop Insulin Delivery
Use of a PID (Proportional-Integral-Derivative) Controller Versus an MPC (Model Predictive Control) Controller Algorithm and Health Monitoring System (HMS) for Closed-Loop Insulin Delivery
Status: Enrolling
Updated:  7/20/2016
William Sansum Diabetes Center
mi
from
Santa Barbara, CA
MPC Versus PID for Closed Loop Insulin Delivery
Use of a PID (Proportional-Integral-Derivative) Controller Versus an MPC (Model Predictive Control) Controller Algorithm and Health Monitoring System (HMS) for Closed-Loop Insulin Delivery
Status: Enrolling
Updated: 7/20/2016
William Sansum Diabetes Center
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Pilot Study Using Weightloss and Exercise to Prevent Recurring Gestational Diabetes in Obese Women
Prevention of Gestational Diabetes Pilot Study
Status: Enrolling
Updated:  7/25/2016
Sierra Vista Regional Medical Center
mi
from
San Luis Obispo, CA
A Pilot Study Using Weightloss and Exercise to Prevent Recurring Gestational Diabetes in Obese Women
Prevention of Gestational Diabetes Pilot Study
Status: Enrolling
Updated: 7/25/2016
Sierra Vista Regional Medical Center
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Long Beach, CA
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Norwalk, CT
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Norwalk, CT
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Clearwater, FL
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Plantation, FL
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Plantation, FL
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Idaho Falls, ID
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
North Chicago, IL
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
North Chicago, IL
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Baltimore, MD
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Boston, MA
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Columbia, MO
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
New York, NY
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Columbia, SC
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
San Antonio, TX
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated:  7/25/2016
mi
from
Vancouver,
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
LY333531 Treatment of Symptomatic Peripheral Neuropathy in Patients With Diabetes
Status: Enrolling
Updated: 7/25/2016
mi
from
Vancouver,
Click here to add this to my saved trials
Effect of LY333531 on Vascular and Neural Functions
The Effects of a Protein Kinase C Beta Inhibitor, LY333531, on Vascular and Neural Functions in Type 2 Diabetes Mellitus - Study B7A-MC-MBDM
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Boston, MA
Effect of LY333531 on Vascular and Neural Functions
The Effects of a Protein Kinase C Beta Inhibitor, LY333531, on Vascular and Neural Functions in Type 2 Diabetes Mellitus - Study B7A-MC-MBDM
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus
The Effect of Protein Kinase C (PKC) β Specific Inhibitor on Oxidant Stress in Patient With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/25/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus
The Effect of Protein Kinase C (PKC) β Specific Inhibitor on Oxidant Stress in Patient With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/25/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
Status: Enrolling
Updated:  7/26/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
Resilience Promotion in Teens With Type 1 Diabetes: Preventing Negative Outcomes
Status: Enrolling
Updated: 7/26/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Status: Enrolling
Updated:  7/28/2016
Yale University School of Medicine
mi
from
New Haven, CT
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Status: Enrolling
Updated: 7/28/2016
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Tucson, AZ
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Buena Park, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Buena Park, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Calabasas, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
mi
from
Calabasas, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Fresno, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Santa Ana, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Centennial, CO
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Trumbull, CT
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Washington,
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Clearwater, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Delray Beach, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Jacksonville, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Miami, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials